ETF Channels
ETF Strategist
Relative Value
Core ETF
Multi-Asset
Equity ETF
Smart Beta
Innovative ETFs
Tactical Allocation
Thematic Investing
Fixed Income
Alternatives
Leveraged & Inverse
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – PowerShares QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top 34 Gold ETFs
Top 34 Oil ETFs
Top 130 Commodity ETFs
Top 47 Hedge Fund ETFs
Top 57 Financials ETFs
Top 68 Inverse Equities ETFs
Top 56 High Yield Bond ETFs
ETF Topics
New ETFs
ETF Investing
Equity ETFs
Alternative ETFs
ETF Ecosystem
ETF Education
Education Central
Video
Podcasts
ETF Playbook
Free Sign Up
Salix
Featured
Salix Bidding War Provides Modest Boost for Pharma ETFs
By
Todd Shriber
March 11, 2015
X
